Its official, Pfizer Canada has joined the worldwide recall for two lots of EpiPens & EpiPen Jr's.
Recalls began in Australia last month and Canada has just released Lot Numbers that may also have a defective part within the pens, causing the auto-injector to fail to activate or require increased force when used.
Products included in the recall are:
- EpiPen (0.3 mg epinephrine) auto-injector lot 5GU763, expiry date May 2017, 67844 units distributed in Canada
- EpiPen Jr (0.15 mg epinephrine) auto-injector lot 5GR765, expiry date March 2017, 39503 units distributed in Canada
What to do next:
- Check your lot numbers and expiry dates to see whether you have the device, best to check your expiry dates in general while you're looking!
- Speak with your pharmacist and arrange replacements of the EpiPen/EpiPen Jr. as soon as possible if required.
- Pfizer Canada is advising patients and caregivers to hold onto the recalled batches of EpiPen/EpiPen Jr. auto-injectors, until you're able to pick up your replacement.
- If a reaction (anaphylaxis) does occur, you can still use your EpiPen/EpiPen Jr. product as prescribed but then seek emergency medical attention immediately.
You can contact Pfizer Canada directly for more information:
By Phone: 1-866-9Pfizer
Toll Free: 1-866-973-4937
By Email: [email protected]
You can contact Health Canada
By Phone: (613) 957-2991
Toll-Free: 1-866 225-0709
If you have experienced adverse reactions or quality problems with the use of this product, please report to 1-866-723-7111. Reports can also be made to Health Canada's Canadian Vigilance Program at 1-866-234-2345.
Comments